SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    ) Venditti, J. M. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary. Cancer Treat. Rep., 67, 767 (1983).
  • 2
    ) Pettit, G. R., Yoshiaki, K., Cherry, L. H., Albert, A. T., Fred, E. B., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B. and Bontems, R. J. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatine 10. J. Am. Chem. Soc., 109, 68836885 (1987).
  • 3
    ) Pettit, G. R., Herald, C. L. and Kamano, Y. Isolation and structure of bryostatin 1. J. Am. Chem. Soc., 104,6846 (1982).
  • 4
    ) Gustafson, K. R., Cardellina, J. H., II, Fuller, R. W., Weislow, O. S., Kiser, R. F., Snader, K. M., Patterson, G. M. L. and Boyd, M. R. AIDS-antiviral sulfolipids from cynobacteria (blue-green algae). J. Natl. Cancer Inst., 81, 12541258 (1989).
  • 5
    ) Sahara, H., Ishikawa, M., Takahashi, N., Ohtani, S., Sato, N., Gasa, S., Akino, T. and Kikuchi, K. In vivo antitumor effect of 3‘-sulphonoquinovosyl 1’-monoacylglyceride isolated from sea urchin (Strongylocentroutus intermedius) intestine. Br. J. Cancer, 75, 324332 (1997).
  • 6
    ) Takahashi, S., Sato, N., Takayama, S., Ichimiya, S., Hyakumachi, N. and Kikuchi, K. Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2Dl-resistant variants of human T cell lines. Eur. J. Immunol., 23, 19351941 (1993).
  • 7
    ) Hannum, Y. A. and Bell, R. M. Lysosphingolipids inhibit protein kinase C: implication for the sphingolipidoses. Science, 235, 670674 (1986).
  • 8
    ) Oishi, K., Raynor, R. L., Charp, P. A. and Kuo, J. F. Regulation of protein kinase C by lysophospholipids. J. Biol. Chem., 263, 68656871 (1988).
  • 9
    ) Merrill, J. A. H. and Stevens, V. L. Modulation of protein kinase C and diverse cell functions by sphingosine—a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochim. Biophys. Acta, 1010, 131139(1989).
  • 10
    ) Sugiyama, E., Uemura, K., Hara, A. and Taketomi, T. Effect of various lysosphingolipids on cell growth, morphology and lipid composition in three neuroblastoma cell lines. Biochem. Biophys. Res. Commun., 169, 673679 (1990).
  • 11
    ) Uehara, K., Sugiyama, E. and Taketomi, T. Effect of an inhibitor of glucosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines. J. Biochem., 110, 96102 (1991).
  • 12
    ) Jenneman, R., Rodden, A., Bauer, B., Mannel, H. D. and Wiegandt, H. Glycosphingolipids of human glioma. Cancer Res., 50, 74447449 (1990).
  • 13
    ) Ohta, K., Mizushina, Y., Hirata, N., Taketomi, M., Sugawara, F., Matsukage, A., Yoshida, S. and Sakaguchi, K. Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerase and HIV-reverse transcriptase type I from a marine red algae, Gigartina tenell. Chem. Pharm. Bull., 46, 684686 (1988).
  • 14
    ) Ohta, K., Mizushina, Y., Hirata, N., Takemura, M., Sugawara, F., Matsukage, A., Yoshida, S. and Sakaguchi, K. Action of a new mammalian DNA polymerase inhibitor, Sulfoquinovosyldiacylglycerol. Biol. Pharm. Bull., 22, 111116 (1999).
  • 15
    ) Golik, J., Dickey, J. K., Todderud, G., Lee, D., Alford, J., Huang, S., Klohr, S., Eustice, D., Aruffo, A. and Agler, M. L. Isolation and structure determination of sulfoquinovosyl dipalmitoyl glyceride, a P-selection receptor inhibitor from the algae Dictyochloris fragrans. J. Nat. Prod., 60, 387389 (1997).
  • 16
    ) Loya, S., Reshef, V., Mizrachi, E., Siberstein, C., Rachamin, Y., Carmeli, S. and Hizi, A. The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: contribution of different moieties to their high potency. J. Nat. Prod., 61, 891895 (1998).
  • 17
    ) Robinson, N. Lysolecithin. J. Pharm. Pharmacol., 13, 321354 (1961).
  • 18
    ) Matsumoto, M. Studies on phospholipids. III. Enzymatic formation of lysophosphatidylethanolamine. J. Biochem., 49, 3237 (1961).
  • 19
    ) Gottfried, E. L. and Rapport, M. M. The biochemistry of plasmalogens: II. Hemolytic activity of some plasmalogen derivatives. J. Lipid Res., 4, 5762 (1963).